Labshake search
Citations for R&D Systems :
451 - 500 of 4972 citations for Recombinant Human Programmed Cell Death 1 His tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biochemistry 2023Quote: Recombinant human angiogenin (catalog number 265-AN/CF) was purchased from R&D Systems, a Bio-Techne Company (Minneapolis ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 20 ng/mL of recombinant human oncostatin M (OSM, R&D systems). For the co-culture experiment ...
-
bioRxiv - Biochemistry 2024Quote: Human recombinant CatA was first activated by following the manufacturer’s instructions (R&D Systems), incubating at 37°C 10 µg/mL CatA with 1 µg/mL CatL in an activation buffer (25 mM MES pH = 6.0 ...
-
bioRxiv - Bioengineering 2024Quote: ... along with 50 ng/ml recombinant human GDNF (R&D Systems, 212-GD-010) were administered for 12 hr ...
-
bioRxiv - Cell Biology 2020Quote: ... media was supplemented with 5 ng/mL recombinant human TGFβ-1 (R&D Systems; resuspended in 4 mM HCl, 0.1% BSA).
-
PVT1, a YAP1 dependent stress responsive lncRNA drives ovarian cancer metastasis and chemoresistancebioRxiv - Cancer Biology 2022Quote: ... epithelial to mesenchymal transition (EMT) was induced with 200 pM of Human recombinant TGF-beta 1 (R&D Systems, 240-B); verteporfin (Sigma Aldrich ...
-
bioRxiv - Cell Biology 2021Quote: ... media was supplemented with 5 ng/mL recombinant human TGFβ-1 (R&D Systems; resuspended in 4 mM HCl, 0.1% BSA). MCF7 ...
-
bioRxiv - Immunology 2020Quote: ... ELISA was performed in 96-well plates coated with 1 μg/mL of human recombinant IL13Rα2hFc (R&D Systems, Minneapolis, MN). Following blocking with PBS/2%FBS and washes with TBS-Tween 20 buffer (Boston Bioproducts ...
-
bioRxiv - Bioengineering 2023Quote: ... Fibroblasts were treated with or without recombinant human transforming growth factor beta 1 (TGF-β1) protein (240-B, R&D Systems) at 1.25 ng/mL ...
-
bioRxiv - Microbiology 2024Quote: ... Monocytes were differentiated into hMDMs for at least 7 days in complete medium containing 10 ng.mL-1 of recombinant human macrophage colony-stimulating factor (rhM-CSF; R&D systems).
-
bioRxiv - Cancer Biology 2021Quote: ... Recombinant SPARC (1 µM; R&D Systems) was incubated with self-activated pseudo-cath-D (5 nM ...
-
bioRxiv - Developmental Biology 2020Quote: ... BMP4 + Activin A treatment was accomplished by treating cells with mTeSR supplemented with 3 ng/mL recombinant human BMP4 protein (R&D Systems) and 100 ng/mL recombinant human Activin A protein (R&D Systems) ...
-
bioRxiv - Biochemistry 2020Quote: In vitro co-precipitation of TREM2 or TREM1 with Aβ oligomers was performed by mixing recombinant Fc-tagged TREM2 or TREM1 ectodomain (residues 19-171; 100 ng/ml, R&D systems), 100 nM HiLyte Fluor 647-labelled Aβ oligomers and Protein G Dynabeads in 0.5% fatty acid free BSA PBS-Tween buffer ...
-
bioRxiv - Immunology 2019Quote: ... Recombinant DLL4 (#1389-D4) and recombinant Jagged-1 (#Q63722) were purchased from R&D systems and coated on plates at the same time as anti-CD3/anti-CD28 ...
-
bioRxiv - Microbiology 2023Quote: ... Cell death inducers in this study included rhTNF-α (210-TA/CF; R&D Systems, Minneapolis MN) and Staurosporine (9953S ...
-
bioRxiv - Immunology 2019Quote: ... and resuspended for culture at 37°C + 5% CO2 for 1 h prior to stimulation with recombinant human TNFα (R&D Systems). Following stimulation ...
-
bioRxiv - Immunology 2020Quote: ... Cells were treated at 37 °C for 30 minutes with 15 μm Forskolin and 1:3 serial dilutions of potential ligands with the following starting concentrations: 10 μM recombinant human CXCL17 (R&D Systems), 10 μM lysophosphatidic acid (LPA ...
-
bioRxiv - Immunology 2023Quote: ... The culture was then diluted 1:50 in 1X PBS + 1% LB broth and incubated statically at 37°C with recombinant human SLPI protein (rSLPI) (CAS: 1274-PI-100, R&D Systems) at these final concentrations ...
-
bioRxiv - Cancer Biology 2024Quote: ... GPC2 CAR expression was determined using APC or PE-conjugated human recombinant GPC2 protein (R&D Systems; 2304-GP-050; 1:500) and CD19 CAR using PE-tagged protein L (58036S ...
-
bioRxiv - Developmental Biology 2019Quote: ... 0.01% of recombinant human FGF basic protein 10μg/ml (R&D Systems, #233-FB-025).
-
bioRxiv - Bioengineering 2021Quote: Recombinant human IDO expressed in Escherichia coli was purchased from R&D Systems (Minneapolis, MN) with a predicted molecular mass of 46 kDa a specific activity of >500pmoles/min/μg (or for equimolar calculations >29 pmol NFK/min/pmol IDO ...
-
bioRxiv - Cancer Biology 2020Quote: ... 10 ng/ml IL6 + 0.1 ng/ml recombinant human sgp130-Fc (R&D Systems, Germany) or 20 ng/ml Hyper-IL6 (kind gift of S ...
-
bioRxiv - Microbiology 2020Quote: ... infected HFF monolayers were stimulated with 100U/mL recombinant human IFN-γ (R&D Systems) 24 hours post-infection and fixed 6 hours post-stimulation ...
-
bioRxiv - Cancer Biology 2020Quote: ... CMK lines were treated with 200 ng/ml of recombinant human WNT3A (R&D systems) for 4 hours ...
-
bioRxiv - Molecular Biology 2022Quote: Human recombinant BMP-2 and BMP-4 were purchase from R&D Systems (Minneapolis, MN). Anti-Myc and anti-HA antibodies were purchased from Cell Signaling Technology (Danvers ...
-
bioRxiv - Cell Biology 2022Quote: ... Recombinant human versican isoform V3 and lumican were from R&D Systems (Minneapolis, MN, USA). Recombinant human versican protein G1 and G3 domains (ab152303 and ab236178 ...
-
bioRxiv - Immunology 2022Quote: ... 625 or 312.5 ng/mL recombinant human IL13Rα1-Fc chimera (R&D Systems Cat#146IR) or IL13Rα2-Fc chimera ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant epidermal growth factor (20 ng/ml; #236-EG-01M, R&D systems, USA), human recombinant fibroblast growth factor (20 ng/ml ...
-
bioRxiv - Pathology 2019Quote: ... Human recombinant PDGF-BB and TNF-α were purchased from R&D Systems (Minneapolis, MN). TRIzol ...
-
bioRxiv - Immunology 2020Quote: ... Monocytes were stimulated for 18hrs with 100U/mL recombinant human IFN-β (R&D systems) and processed for RNA extraction.
-
bioRxiv - Cancer Biology 2019Quote: ... Recombinant Human EGF Protein 10 ng/mL (R&D systems, Cat. No. 236-EG-200), Recombinant Human FGF basic ...
-
bioRxiv - Molecular Biology 2020Quote: ... and BARD1 proteins was conducted using recombinant human ubiquitin (U-100H, R&D system, USA) and HeLa NE as a source of E1 and E2 ligases in 20 mM Tris-HCl pH 7.5 ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems; Bio-techne, Inc.) until use.
-
bioRxiv - Pathology 2021Quote: ... 25 μL of biotinylated recombinant human IL5 (rhIL5) protein (50 μg/mL) (R&D Systems) was added at 1:50 in PBS ...
-
bioRxiv - Physiology 2020Quote: ... with 2 µg of recombinant human TSG-6 (rTSG-6, R&D Systems, Minneapolis, MN) in 100 µl PBS (or with PBS alone ...
-
bioRxiv - Developmental Biology 2019Quote: ... 10 uM SB431542 (SA) and 10 ng/mL recombinant human FGF-2 (R&D Systems) were added on D2 for 2 days ...
-
bioRxiv - Genetics 2020Quote: ... base medium supplemented with 50 ng/ml recombinant human SCF (R&D systems #255-SC), 1 μg/ml doxycycline (Sigma Aldrich #D9891) ...
-
bioRxiv - Biochemistry 2021Quote: ... recombinant human CD45 (cat no. 1430-CD-050) was from R&D Systems (Minneapolis, MN), recombinant human CD45 (cat no ...
-
bioRxiv - Cancer Biology 2021Quote: ... Recombinant human TNFα protein (#210-TA-005) was purchased from R&D Systems (Minneapolis, USA).
-
bioRxiv - Cell Biology 2020Quote: ... with 25 ng/ml recombinant human WNT3A (R&D Systems, cat. no. 5036-WN-010) and 100 ng/ml Activin A (Humanzyme ...
-
bioRxiv - Immunology 2020Quote: ... Recombinant human IL-15 and mouse IL-21 were from R&D Systems (Minneapolis, MN).
-
bioRxiv - Immunology 2020Quote: ... CF (uPA) and Recombinant human NKG2D/CD314 Fc Chimera were purchased from R&D systems. Biotin-Protein L was purchased from GenScript ...
-
bioRxiv - Bioengineering 2022Quote: ... supplemented with 50 ng/mL recombinant human vascular endothelial growth factor (VEGF; R&D Systems), 10 μM Y-27632 ...
-
bioRxiv - Cell Biology 2022Quote: ... they and their controls were treated with recombinant human CXCL12 (R&D Systems, #350-NS) in a biopolymer delivery vehicle (CellMate3D ...
-
bioRxiv - Immunology 2022Quote: ... or 10 ng/mL of recombinant human IL-1β (R&D Systems; 201-LB-005) for the indicated times ...
-
bioRxiv - Neuroscience 2023Quote: ... supplemented with 20 ng/mL recombinant human basic FGF (#233-FB, R&D Systems, Germany) and 10 µM Y-27632 (only for the first 24 h after passaging ...
-
bioRxiv - Systems Biology 2023Quote: ... with 10% Fetal Bovine Serum and 100ng/ml recombinant Human M-CSF (R&D Systems) for 4 days.
-
bioRxiv - Microbiology 2023Quote: ... The recombinant human α-dystroglycan (rhDG) protein was acquired from R&D Systems (MN, USA). The LAMP1 (H4A3 ...
-
bioRxiv - Developmental Biology 2023Quote: ... with 25 ng/ml of recombinant human VEGF-C (Cat#: 9199-VC, R&D Systems) and HUVECs were cultured in complete Endothelial Cell Growth Medium (ECGM ...
-
bioRxiv - Biochemistry 2023Quote: Recombinant Human ACE2 Protein (933-ZN) was purchased from R&D Systems (Minneapolis, MN, U.S.A.) and stored in a buffer according to the manufacturer’s instructions ...